10/8/2018
1
The Big 8:Advances in Food Allergy Risk Assessment and Management
October 11, 2018
Food Allergies: What are the Challenges?
Stefano Luccioli, MDUS FDA, Center for Food Safety and Applied Nutrition (CFSAN)
Medical Officer, Food Allergen Program Coordinator
Office of Compliance
5001 Campus Drive, HFS-605
College Park, MD 20740
Tel: 240-402-1283
Cell: 202-577-1687
10/8/2018
2
Conflict of Interest Statement
• I have no conflicts of interest to declare
• Disclaimer:
The views and clinical perspectives expressed in this presentation are those of the Author and do not necessarily represent the views of the Food And Drug Administration
Focus of discussion
Regulatory public health safety and management perspective
• Define food allergy
• Discuss unique mechanisms, prevalence, diagnostic and risk considerations and public health burden
• Discuss key FDA/regulatory activities and challenges in food allergen avoidance and management
• Data gaps and future goals
10/8/2018
3
Clinical case
• 46 yo male
• Longstanding springtime allergies, mild asthma, penicillin allergy
• Eating left-over tuna steak from last night’s dinner
• Develops immediate flushing, headache, diarrhea, shortness of breath and high blood pressure
• Is this a food allergy?
• No, likely Scombroid food poisoning (toxic reaction)
http://www3.niaid.nih.gov/topics/foodAllergy/clinical/PDF/guidelines.pdf
Adverse reactions to food
“Allergies”
*Gluten
10/8/2018
4
“Food Allergy”
Adverse reaction to food that is IgE antibody-mediated– “immediate gastrointestinal allergy/anaphylaxis”
Involves foods/proteins commonly consumed in diet
US: peanut, soy, egg, milk, wheat, tree nuts, fish, shellfish– Sesame, mustard, celery, lupin, buckwheat..
Affects 3-4% of Americans, mostly children
Genetic AND environmental
Lifetime risk for many
No effective treatment (?) – Labeling/ avoidance is key!
B cell T cell
Food protein
IgEAntibody
Mast cell/ Basophil
Sensitization
Elicitation/ Reactivity
Breakdown in oral tolerance
? Cause – dose, length or timing of exposure
One dose exposure/ above threshold
Amplification mechanism –severity endpoints variable
10/8/2018
5
Sampson 2018
Urticaria (hives))Angioedema(swelling) Conjunctivitis
FlushingHypotension
10/8/2018
6
Food allergy eliciting symptoms
Skin- itchiness, flushing, hives, swelling, conjunctivitis, eczema
GI- nausea, abdominal pain, vomiting, diarrhea
Respiratory- chest tightness, runny nose, wheezing, throat closing/swelling
Vascular- dizziness, fainting, arrythymias, hypotension, shock
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐
Subjective Objective Anaphylaxis Death
EDII
EDII
EDII
EDII
Severity Continuum
ED=eliciting dose
EDII
EDII
EDII
Prevalence
Food *Children *Adults ^Objective
Milk 2.5% 0.3% 0.6-0.9%
Egg 1.3% 0.2% 0.3-0.9%
Peanut 0.8% 0.6% 0.4-0.8%
Tree nut 0.2% 0.5% 0.4%
Fish 0.1% 0.4% 0.2-0.3%
Shellfish 0.1% 2.0% 0.6%
Other - - Soy – 0.03-0.7%
Wheat- 0.2-1.2%
Total 6% 3.7% 3.0%
*Sampson, JACI, May 2004;
^NIH clinical guidelines, 2010
#Savage et al, JACI In Pract2016
FA: Self-reported (9- 13%) >> clinically diagnosed (3-4%); Infants >> adults Surveys: FA prevalence in US children doubled 1997-2007 (peanut); ↑ self-report in US adults
10/8/2018
7
Diagnosis
Observed history of characteristic allergic reaction symptoms to food **AND
Positive food skin prick test (SPT) or serum food-specific IgE
AND/OR
Positive oral food challenge (DBPCFC) – gold standard
**History alone or evidence of positive IgE test alone is NOTdiagnostic
Food Challenge
Dose escalation study of X dose (increment varies 2-10) to final dose (*)
Use for diagnosis, therapeutic trial and threshold assessment
Report LOAEL or eliciting dose - discrete (4X) or cumulative (7X)
Adverse effect= objective sign (? subjective symptoms)
X 2X 4X 8X 16X 32X 64X 108X *
Time[15 min –hours]
LOAELNOAEL
4X
7XAdverse
effect
10/8/2018
8
Population sensitivities
• Large (million-fold) inter-individual variability in eliciting dose responses
• Individual eliciting dose thresholds may vary from one exposure to next
• Minimal data on doses associated with severe reactions
Diagnostic considerations/ limitations
Poor risk prediction – to low dose and identifying severe responders– No valid biomarkers
– Symptoms or prior reaction history unreliable
– Food challenge is best tool but underutilized Mostly diagnostic tool –yes or no allergy
Utility to determine threshold and future risk of reactions?
No available treatments or prevention strategies
Most clinicians give patients the same advice about risks -everybody is at risk for severe, life-threatening reactions
10/8/2018
9
Public health burden
• Reactions/ Anaphylaxis in community common− Surveys: 30-50% report >1 reactions in past year [Verrill 2016]
2-3%(0.5%-anaphylaxis) of all CAERS food complaints [Oladipo 2014]
− #1 cause of ED visits: 20-30,000/yr; ≈ 2500 hospitalizations (↑) [Ross 2008]
− Deaths (150?): ≈ 20-30/ yr (teenagers)
− Tree nuts and peanuts most commonly involved
• Psychosocial impact = decreased quality of life (QOL)− Similar to chronic illness; limited food choices; anxiety/ fear of death from
accidental exposures; social stigma/ bullying, etc.
• ‘Allergic march’- development of asthma and/or other comorbidities
• Economic costs (?), poor nutrition
Food allergen avoidance and management
Avoidance is difficult – Allergenic food hazards are everywhere and not always labeled
– Proliferation of allergen labels and advisory statements limits food choices
Food allergen information often does not inform risk– Different doses and types of allergens in products
– Multiple types of advisory statements and cross contact risks- not linked to risk
Lack of training/knowledge in clinical community of food allergen labeling and risks in products– Avoidance advice and risk perceptions vary
– + risk taking: 30-40% report ignoring advisory statements [Marchisotto 2016]
– 8-31% of accidental reactions due to disregarding labels
10/8/2018
10
Blom et al. Accidental food allergy reactions: Products and undeclared ingredients. JACI. 2018; 142(3):865-875
Food allergen avoidance and management
• Allergenic food hazards difficult to control − Undeclared allergens have become most
common cause of food product recalls (30-40%) • Most likely cause is labeling error [Gendel 2013]
− Global food market – novel or emerging allergens
− Variable levels of allergen hazard from cross contact • dark chocolate (milk) is high risk product [ Bedford 2017]
− Analytical detection methods may be limited
− No thresholds established− No mechanism to distinguish low from high risk products
National Academy of Sciences study on food allergies (Nov, 2016) –recommended need for risk-based labeling approach
10/8/2018
11
Regulatory activities involving food allergies
CFSAN mission: ensuring that the nation's food supply is safe, sanitary, wholesome, and honestly labeled
• Implementation of food allergen labeling laws
• Compliance/ enforcement - Inspections and recalls
• Analytical methods to detect allergens in food
• Safety/risk assessments
• Postmarket surveillance – Medwatch and districts (CAERS)
• Policy, guidance and consumer education
Regulatory activities involving food allergies
Other FDA offices:
• Oral desensitization studies, allergen extracts, allergens in vaccines (CBER)
• Anaphylaxis treatment (e.g., Epinephrine autoinjectors), food allergen labeling in drugs (CDER)
• GM salmon (CVM)
Other agencies:
• TTB : distilled spirits, wine, beers with malted barley
• USDA: meat, poultry and some egg products (>2%)
• EPA: pesticides
10/8/2018
12
Food Allergen Labeling & Consumer Protection Act of 2004 (FALCPA)
FALCPA
• Involves packaged food and dietary supplements− Not drugs, cosmetics, other consumer products
− Not foods sold in most retail/ food service establishments
• Does not address unintentional introduction of allergens into products by “cross-contact” Manufacturers may voluntarily place allergen advisory or precautionary
allergen labeling (PAL) statements (‘may contain’, etc) to alert consumers
Regulatory concerns: truthful and not misleading? Not used in lieu of good manufacturing practices (GMPs)?
Industry concerns: Need for advisory statement?
10/8/2018
13
FDA Food Safety Modernization Act (FSMA) Final Rule for Preventive Controls for Human Food (2015)
• Defines “cross contact”
• Facilities that use major food allergens must establish and implement a food safety plan that includes an analysis of hazards and risk-based preventive controls
− Prevent allergen cross contact
− Ensure accurate labeling of finished foods
− Training
• Testing not required for validation; no thresholds establishedIndustry concern- How clean is clean?
• Guidance pending
Regulatory risk assessment and management
• Allergenicity of novel foods
• Health claims to prevent allergies
• Risk-based allergen thresholds
Exemptions from labeling requirements
Undeclared allergen hazard evaluations/ Recalls
Cross contact/ preventive controls
Public health needs
10/8/2018
14
Food allergy management issues and challenges
• Prevention of food allergies
• Novel foods/ cross-reactivity
• Thresholds
• Undeclared allergen and health hazard assessment
• Severity
• Diagnosis and risk prediction/communication
Novel foods/ proteins
Main question: Does the new protein have characteristics of a known allergenic epitope and/or can it bind IgE?
Focus on potential for sensitization - not always indicative of clinical reactivity or cross-reactivity
Source of protein
Amino acid sequence homology
Pepsin resistance
Specific serum screening
Optional: Targeted serum, animal models
High protein foods (e.g.pea, insect) – cross-reactivity concerns
EpitopeIgE (food-specific or crossreactive)
Codex Alimentarius, 2003
10/8/2018
15
camelLuccioli et al, in Immunology IV textbook 2012
Cross-reactive Food Allergies
Risk of reactivity (to at least one)
Lupin- 30%(?)
Insect proteins(?)
Threshold types
Individual
Population (most data)
Analytical
Regulatory
10/8/2018
16
FALCPA Labeling exemptions
• Statutory exemption: highly refined oils from MFA• Ingredient exemption standards:
“does not contain allergenic protein”Ex: Ice structuring protein (ISP- fish) “does not cause an allergic response that poses risk to human
health” [severity component]Ex: Solae-brand soy lecithin as release agent
Draft Guidance to Industry –Food Allergen Labelling Exemption Petitions and Notifications (May, 2014)
No thresholds defined by FALCPA
“Approaches to Establish Thresholds for Major Food Allergens and for Gluten in Food” (Journal of Food Protection.2008. 71(5):1043–88)
• Analytical methods-based− Is it there or not? peanut, milk, egg, gluten, hazelnut, almond, walnut, soy [ELISA] XMAP -14 food allergens + gluten
• Safety assessment-based• LOAEL/NOAEL + safety factors → ADI (“safe” dose)
• Risk assessment-based*• Risk in relation to dose, exposure – most robust• Threshold dose= interval between LOAEL and NOAEL• Used to propose risk-based reference doses for
advisory labeling (VITAL –Taylor EDx: Estimated dose to cause X% of population to react
10/8/2018
17
Population ED severity data
Analysis of peanut and milk EDs based on reaction severity score (mild, moderate, severe) using integrated scoring system (Zhu 2015)
Peanut may be different from milk, soy*
350+ peanut allergic individuals were fed a “one shot” dose equivalent to ED05 dose and none had severe reaction
Products with undeclared allergen - Need for recall? Determine class of recall? Class I: reasonable probability of serious health consequences Class II: temporary/reversible; serious consequences are remote Class III: not likely to cause adverse health consequences
Food recall hazard determinations
Case by case basis: have begun using population threshold information to
inform class I vs class II allergen recalls [with mitigating factor information]
Determining class III still a challenge
Undeclared allergen hazards and Recalls
10/8/2018
18
Cross contact/ preventive controls
Benefits public health
Prevent label confusion, risk taking
Good data quality and transparency
Is practical and enforceable
Prevent accidental reactions
Request for comments and information on Risk Assessment for Establishing Allergen Thresholds (Dec, 2012 – May, 2013) 405 submissions to docket 50% from consumers opposed to threshold concept; three
patient organizations expressed caution as well Industry and trade groups uniformly in favor of thresholds
Consumers/public are still unsure by thresholds
Need to develop outreach tools to educate consumers and clinicians about thresholds and reactivity risks
Thresholds- public health
10/8/2018
19
Current goals
Education of public and physicians about thresholds and risks of advisory statements
Encourage more diagnostic procedures to understand thresholds Implementation of FSMA
– Increase compliance with allergen label controls to reduce allergen recalls from preventable errors
– Allergen preventive control guidance pending; exploring risk-based strategies for addressing allergen cross contact
Independent data quality assessment of existing threshold data– Continue participation in global threshold discussions– Continue analytical test method development for all food allergens
Thank you for your attention
10/8/2018
20
References
Bedford B, Yu Y, Wang X et al. A Limited Survey of Dark Chocolate Bars Obtained in the United States for Undeclared Milk and Peanut Allergens. J Food Prot. 2017;80(4):692-702.
Blom M, Michelsen-Huisman AH, van Os-Medendorp H et al. Accidental food allergy reactions: Products and undeclared ingredients. JACI 2018;142(3):865-875
Gendel SM, Zhu J. Analysis of U.S. Food and Drug Administration food allergen recalls after implementation of the food allergen labeling and consumer protection act. J Food Prot. 2013;76(11):1933-8
Marchisotto MJ, Harada L, Kamdar O et al. Food Allergen Labeling and Purchasing Habits in the United States and Canada. JACI Pract. 2017;5(2):345-351
Oladipo T and Luccioli S. Prevalence and Characteristics of Consumer-Reported Food Allergic and Anaphylactic Events in CAERS, 2007-2011. JACI. 2014. 133(2):S207 [abstract]
NIAID-Sponsored Expert Panel, Boyce JA, Assa'ad A, Burks AW, et al. 2010. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. Journal of Allergy and Clinical Immunology 126(6 Suppl):S1-58.
Ross MP, Ferguson M, Street D et al. Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System. JACI 2008;121:166-71
References
Sampson HA, O'Mahony L, Burks AW et al. Mechanisms of food allergy. JACI 2018;141(1):11-19.
Taylor SL, Baumert JL, Kruizinga AG, et al. Establishment of Reference Doses for residues of allergenic foods: report of the VITAL Expert Panel. Food Chem Toxicol. 2014;63:9-17
Verrill L, Bruns R, Luccioli S. Prevalence of self-reported food allergy in U.S. adults: 2001, 2006, and 2010. Allergy Asthma Proc. 2015;36(6):458-67
Zhu J, Kwegyir-Afful EJ, Luccioli S et al. A Retrospective Analysis of Allergic Reaction Severities and Minimal Eliciting Doses for Peanut, Milk, Egg, and Soy Oral Food Challenges. Food Chem Toxicol. 2015;80:92-100.